157 related articles for article (PubMed ID: 38590403)
1. Nanostructured lipid carriers loaded with morellic acid for enhanced anticancer efficacy: preparation, characterization, pharmacokinetics and anticancer evaluation.
Jia B; Li S; Li L; Wang T; Chen W; Chen G
Am J Cancer Res; 2024; 14(3):1101-1120. PubMed ID: 38590403
[TBL] [Abstract][Full Text] [Related]
2. Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers.
Yu G; Ali Z; Sajjad Khan A; Ullah K; Jamshaid H; Zeb A; Imran M; Sarwar S; Choi HG; Ud Din F
Int J Nanomedicine; 2021; 16():3255-3273. PubMed ID: 34012260
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol: Isolation, and Its Nanostructured Lipid Carriers, Inhibits Cell Proliferation, Induces Cell Apoptosis in Certain Human Cell Lines Carcinoma and Exerts Protective Effect Against Paraquat-Induced Hepatotoxicity.
Elgizawy HA; Ali AA; Hussein MA
J Med Food; 2021 Jan; 24(1):89-100. PubMed ID: 32580673
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluation of folate-mediated PEGylated nanostructured lipid carriers for the efficient delivery of furanodiene.
Zhang J; He Y; Jiang J; Li M; Jin C; Wang L; Wang D
Drug Dev Ind Pharm; 2017 Oct; 43(10):1610-1618. PubMed ID: 28481661
[TBL] [Abstract][Full Text] [Related]
5. Dermatokinetic assessment of luliconazole-loaded nanostructured lipid carriers (NLCs) for topical delivery: QbD-driven design, optimization, and in vitro and ex vivo evaluations.
Mahmood A; Rapalli VK; Gorantla S; Waghule T; Singhvi G
Drug Deliv Transl Res; 2022 May; 12(5):1118-1135. PubMed ID: 33895936
[TBL] [Abstract][Full Text] [Related]
6. Comparative of
Abedi Gaballu F; Abbaspour-Ravasjani S; Mansoori B; Yekta R; Hamishehkar H; Mohammadi A; Dehghan G; Shokouhi B; Ghahremani Dehbokri S; Baradaran B
Iran J Pharm Res; 2019; 18(3):1168-1179. PubMed ID: 32641930
[TBL] [Abstract][Full Text] [Related]
7. Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy.
Chen Z; Lai X; Song S; Zhu X; Zhu J
Drug Deliv; 2016 May; 23(4):1369-73. PubMed ID: 26017099
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, and in vivo pharmacokinetics of nanostructured lipid carriers loaded with oleanolic acid and gentiopicrin.
Zhang K; Lv S; Li X; Feng Y; Li X; Liu L; Li S; Li Y
Int J Nanomedicine; 2013; 8():3227-39. PubMed ID: 24009420
[TBL] [Abstract][Full Text] [Related]
9. Repaglinide-loaded nanostructured lipid carriers with different particle sizes for improving oral absorption: preparation, characterization, pharmacokinetics, and
Wu L; Zhao L; Su X; Zhang P; Ling G
Drug Deliv; 2020 Dec; 27(1):400-409. PubMed ID: 31729898
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
Noor NM; Sheikh K; Somavarapu S; Taylor KMG
Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
[TBL] [Abstract][Full Text] [Related]
11. Levosulpiride-loaded nanostructured lipid carriers for brain delivery with antipsychotic and antidepressant effects.
Maqsood S; Din FU; Khan SU; Elahi E; Ali Z; Jamshaid H; Zeb A; Nadeem T; Ahmed W; Khan S; Choi HG
Life Sci; 2022 Dec; 311(Pt B):121198. PubMed ID: 36396112
[TBL] [Abstract][Full Text] [Related]
12. Co-Delivery of erlotinib and resveratrol via nanostructured lipid Carriers: A synergistically promising approach for cell proliferation prevention and ROS-Mediated apoptosis activation.
Asadollahi L; Mahoutforoush A; Dorreyatim SS; Soltanfam T; Paiva-Santos AC; Peixoto D; Veiga F; Hamishehkar H; Zeinali M; Abbaspour-Ravasjani S
Int J Pharm; 2022 Aug; 624():122027. PubMed ID: 35850183
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization and pharmacokinetic studies of linalool-loaded nanostructured lipid carriers.
Shi F; Zhao Y; Firempong CK; Xu X
Pharm Biol; 2016 Oct; 54(10):2320-8. PubMed ID: 26986932
[TBL] [Abstract][Full Text] [Related]
14. Preparation of Ergosterol-Loaded Nanostructured Lipid Carriers for Enhancing Oral Bioavailability and Antidiabetic Nephropathy Effects.
Dong Z; Iqbal S; Zhao Z
AAPS PharmSciTech; 2020 Jan; 21(2):64. PubMed ID: 31932990
[TBL] [Abstract][Full Text] [Related]
15. Nanostructured Lipid Carriers Loaded with Baicalin: An Efficient Carrier for Enhanced Antidiabetic Effects.
Shi F; Wei Z; Zhao Y; Xu X
Pharmacogn Mag; 2016; 12(47):198-202. PubMed ID: 27601850
[TBL] [Abstract][Full Text] [Related]
16. Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy.
Zhang G; Liu F; Jia E; Jia L; Zhang Y
Drug Deliv; 2016 May; 23(4):1393-7. PubMed ID: 26165422
[TBL] [Abstract][Full Text] [Related]
17. Targeted Nanostructured Lipid Carrier for Brain Delivery of Artemisinin: Design, Preparation, Characterization, Optimization and Cell Toxicity.
Emami J; Yousefian H; Sadeghi H
J Pharm Pharm Sci; 2018; 21(1s):225s-241s. PubMed ID: 30266137
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system.
Zhang S; Lu C; Zhang X; Li J; Jiang H
Drug Deliv; 2016 Jun; 23(5):1838-45. PubMed ID: 26879035
[TBL] [Abstract][Full Text] [Related]
19. S-Protected thiolated nanostructured lipid carriers exhibiting improved mucoadhesive properties.
Arshad S; Masood-Ur-Rehman ; Hussain Asim M; Nazir I; Shahzadi I; Mousli M; Bernkop-Schnürch A
Int J Pharm; 2020 Sep; 587():119690. PubMed ID: 32738459
[TBL] [Abstract][Full Text] [Related]
20. Optimization of Tilmicosin-Loaded Nanostructured Lipid Carriers Using Orthogonal Design for Overcoming Oral Administration Obstacle.
Wen J; Gao X; Zhang Q; Sahito B; Si H; Li G; Ding Q; Wu W; Nepovimova E; Jiang S; Wang L; Kuca K; Guo D
Pharmaceutics; 2021 Feb; 13(3):. PubMed ID: 33669090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
